Paper
RSC Advances
1452, 1371 cmꢁ1
;
1H NMR (400 MHz, CDCl3) d 7.37–7.29 (m, ¼ 2.8 Hz, 0.6H), 3.68–3.62 (m, 2H), 3.55 (d, J ¼ 9.5 Hz, 1H), 3.52–
5H), 5.30 (t, J ¼ 10.0 Hz 1H), 4.91 (d, J ¼ 3.6 Hz, 1H), 4.87 (dd, J ¼ 3.49 (m, 1H), 3.34 (dd, J ¼ 10.2, 8.0 Hz, 0.8H), 3.28 (dd, J ¼ 10.5,
10.1, 3.6 Hz, 1H), 4.60 (q, J ¼ 12.0 Hz, 2H), 3.80–3.70 (m, 4H), 3.4 Hz, 1H), 2.16 (s, 3H), 2.15 (s, 2H); 13C NMR (100 MHz, CDCl3)
3.40 (s, 3H), 2.83 (s, 1H), 2.09 (s, 3H), 2.08 (s, 3H).; 13C NMR (100 d 172.0, 171.8, 137.3, 137.2, 128.53, 128.5, 128.02, 127.98, 95.9,
MHz, CDCl3) d 176.8, 171.3, 170.2, 137.7, 128.3, 127.6, 127.5, 91.9, 75.7, 74.6, 73.7, 73.6, 73.5, 70.5, 70.3, 70.1, 69.5, 69.4, 64.5,
96.6, 73.5, 72.9, 70.7, 70.1, 70.0, 69.2, 55.1, 20.8, 20.6; HRMS 61.4, 21.0; HRMS (ESI, M + Na+) calcd for C15H19O6N3Na
(ESI, M + Na+) calcd for C18H24O8Na 391.1369, found 391.1362. 360.1172, found 360.1164.
4-Methylphenyl 2,3-di-O-acetyl-6-O-benzyl-1-thio-b-D-gluco-
4-Methylphenyl 3-O-acetyl-6-O-benzyl-2-deoxyl-2-phthalimi-
pyranoside (6b). Prepared according to the general procedure do-1-thio-b-D-glucopyranoside (6f). Prepared according to the
discussed above: yellow oil (83 mg, 82%); Rf 0.25 (EtOAc/Hex ¼ general procedure discussed above: white solid (159 mg,
1/2); [a]2D6 ꢁ37.4 (c 0.8, DCM); IR (NaCl) n 3478, 3030, 2920, 1752, 80%); Rf 0.38 (EtOAc/Hex ¼ 1/1); mp 54–56 C; [a]D +17.0 (c
23
ꢀ
1494, 1373 cmꢁ1
;
1H NMR (400 MHz, CDCl3) d 7.40–7.28 (m, 1.0, DCM); IR (NaCl) n 3478, 3030, 2922, 2855, 1750, 1494,
7H), 7.08 (d, J ¼ 8.4 Hz, 2H), 5.06 (t, J ¼ 9.6 Hz, 1H), 4.90 (dd, J ¼ 1430, 1369 cmꢁ1; H NMR (400 MHz, CDCl3) d 7.89–7.84 (m,
9.6, 9.2 Hz, 1H), 4.63 (d, J ¼ 10.0 Hz, 1H), 4.57 (d, J ¼ 5.2 Hz, 2H), 2H), 7.77–7.72 (m, 2H), 7.40–7.31 (m, 5H), 7.29 (d, J ¼ 8.2 Hz,
3.80 (dd, J ¼ 6.4, 4.8 Hz, 2H), 3.72 (t, J ¼ 9.4 Hz, 1H), 3.58–3.52 2H), 7.03 (d, J ¼ 7.9 Hz, 2H), 5.68–5.61 (m, 2H), 4.60 (q, J ¼
(m, 1H), 2.32 (s, 3H), 2.09 (s, 3H), 2.07 (s, 3H).; 13C NMR (100 11.8 Hz, 2H), 4.26 (t, J ¼ 10.4 Hz, 1H), 3.88–3.72 (m, 4H), 2.91
MHz, CDCl3) d 171.2, 169.5, 138.4, 137.6, 133.4, 129.6, 128.4, (s, 1H), 2.29 (s, 3H), 1.91 (s, 3H); 13C NMR (100 MHz, CDCl3)
128.0, 127.8, 127.6, 85.8, 78.4, 76.7, 73.7, 70.0, 69.9, 69.87, 21.1, d 171.1, 167.8, 167.3, 138.4, 137.7, 134.3, 134.1, 133.5, 131.6,
20.8.; HRMS (ESI, M+Na+) calcd for C24H28O7SNa 483.1453, 131.2, 129.6, 128.4, 127.8, 127.7, 127.5, 123.6, 123.5, 83.2,
1
found 483.1446.
78.3, 74.3, 73.7, 71.0, 70.2, 53.6, 52.6, 21.1, 20.7, 20.5, 13.9;
4-Methylphenyl
2,3,6-tri-O-benzyl-1-thio-b-D-glucopyrano- HRMS (ESI, M + Na+) calcd for C30H29NO7SNa 570.1562,
side (6c). Prepared according to the general procedure dis- found 570.1561.
cussed above: yellow oil (86 mg, 86%); Rf 0.25 (EtOAc/Hex ¼ 1/2);
26
Glycosylation reactions
ꢀ
mp 62–64 C; [a]D ꢁ7.4 (c 0.8, DCM); IR (NaCl) n 3478, 3030,
2920, 1752, 1494, 1373 cmꢁ1; 1H NMR (400 MHz, CDCl3) d 7.46
2-Azido-2-deoxy-3-O-acetyl-6-O-benzyl-1-O-tert-butyldime-
(d, J ¼ 8.1 Hz, 2H), 7.44–7.40 (m, 2H), 7.38–7.27 (m, 13H), 7.05 thylsilyl-4-O-(3-O-ace-tyl-4,6-O-benzylidene-2-deoxy-2-phthali-
(d, J ¼ 7.9 Hz, 2H), 4.93 (d, J ¼ 4.4 Hz, 1H), 4.90 (d, J ¼ 6.0 Hz, mido-b-D-glucopyranosyl)-b-D-glucopyranoside (13). A solution
1H), 4.76 (dd, J ¼ 16.0, 15.2 Hz, 2H), 4.63 (d, J ¼ 9.6 Hz, 1H), 4.57 of acceptor 6g (50 mg, 0.11 mmol), donor 5f (120 mg, 0.22
ꢀ
(d, J ¼ 4.4 Hz, 2H), 3.77 (t, J ¼ 5.0 Hz, 2H), 3.64 (t, J ¼ 9.2 Hz, mmol), and activated 4 A molecular sieves (300 mg) in
1H), 3.53 (t, J ¼ 8.6 Hz, 1H), 3.49–3.42 (m, 2H), 2.55 (s, 1H), 2.31 dichloromethane (1 mL) was stirred for 30 minutes at room
(s, 3H).; 13C NMR (100 MHz, CDCl3) d 138.4, 138.2, 138.1, 138.0, temperature. Aer N-iodosuccinimide (148 mg, 0.66 mmol)
137.9, 137.7, 132.6, 129.7, 129.6, 128.6, 128.4, 128.37, 128.2, and dried phosphotungstic acid (158 mg, 0.055 mmol) were
127.9, 127.7, 87.9, 86.1, 80.4, 78.0, 75.5, 75.3, 73.6, 71.6, 70.3, added, the reaction mixture was stirred for 5 hours. When
21.1; HRMS (ESI, M + Na+) calcd for C34H36O5SNa 579.2181, the reaction was completed, molecular sieves were removed
found 579.2184.
by ltration through Celite. The ltrate was extracted with
4-Methylphenyl
2,3-di-O-acetyl-6-O-benzyl-1-thio-b-D-gal- aqueous sodium thiosulfate (10 mL) and brine (10 mL), and
acopyranoside (6d). Prepared according to the general proce- the organic layer was dried over anhydrous MgSO4, ltered,
dure discussed above: white solid (80 mg, 79%); Rf 0.50 (EtOAc/ and concentrated under vacuum. The residue was puried by
Hex ¼ 1/1); mp 114–115 ꢀC; [a]2D6 +1.8 (c 0.8, DCM); IR (NaCl) n column chromatography on silica gel to give the desired
1
3478, 3030, 2922, 1750, 1494, 1369 cmꢁ1; H NMR (400 MHz, product 13 (79 mg, 82%) as a white soild. Rf 0.47 (EtOAc/Hex
24
ꢀ
CDCl3) d 7.41 (d, J ¼ 8.0 Hz, 2H), 7.36–7.29 (m, 5H), 7.07 (d, J ¼ ¼ 1/2); mp 112–114 C; [a]D ꢁ13.4 (c 1.0, DCM); IR (NaCl) n
8.1 Hz, 2H), 5.27 (t, J ¼ 9.8 Hz, 1H), 4.96 (dd, J ¼ 9.6, 3.0 Hz, 1H), 3479, 2931, 2112, 1751, 1720, 1386, 1227, 1105, 1082 cmꢁ1
;
4.63 (d, J ¼ 10.0 Hz, 1H), 4.56 (d, J ¼ 4.8 Hz, 2H), 4.17 (t, J ¼ 1H NMR (400 MHz, CDCl3) d 7.83 (dd, J ¼ 5.5, 3.1 Hz, 2H),
3.2 Hz, 1H), 3.78 (t, J ¼ 4.4 Hz, 2H), 3.71 (t, J ¼ 5.0 Hz, 1H), 2.64– 7.71 (dd, J ¼ 5.5, 3.0 Hz, 2H), 7.46 (d, J ¼ 4.4 Hz, 1H), 7.44 (d, J
2.59 (m, 1H), 2.31 (s, 3H), 2.08 (s, 3H), 2.07 (s, 3H); 13C NMR (100 ¼ 2.1 Hz, 1H), 7.38–7.35 (m, 3H), 7.32–7.27 (m, 3H), 7.21–
MHz, CDCl3) d 170.2, 169.5, 164.8, 155.2, 138.3, 137.5, 133.3, 7.19 (m, 2H), 5.84 (dd, J ¼ 10.2, 9.4 Hz, 1H), 5.52 (s, 1H), 5.50
129.6, 128.5, 128.3, 127.9, 127.8, 86.5, 76.7, 74.5, 73.8, 69.5, 68.3, (d, J ¼ 8.4 Hz, 1H), 4.90 (dd, J ¼ 10.4, 9.2 Hz, 1H), 4.47 (d, J ¼
67.6, 29.7, 21.2, 20.9; HRMS (ESI, M + Na+) calcd for 8.0 Hz, 1H), 4.39–4.36 (m, 2H), 4.26 (d, J ¼ 12.0 Hz, 1H), 4.21
C
24H28O7SNa 483.1453, found 483.1458.
(dd, J ¼ 10.4, 8.4 Hz, 1H), 3.93 (t, J ¼ 9.6 Hz, 1H), 3.79–3.70
3-O-Acetyl-2-azido-6-O-benzyl-2-deoxyl-D-glucopyranoside
(m, 2H), 3.65–3.59 (m, 1H), 3.36–3.33 (m, 1H), 3.30–3.25 (m,
(6e). Prepared according to the general procedure discussed 3H), 2.15 (s, 3H), 1.86 (s, 3H), 0.88 (s, 9H), 0.07 (s, 3H), 0.07
above: colorless liquid (52 mg, 69%), a/b ¼ 3/2; Rf 0.30 (EtOAc/ (s, 3H); 13C NMR (101 MHz, CDCl3) d 170.1, 169.2, 137.8,
Hex ¼ 1/1); [a]2D5 ꢁ5.5 (c 0.6, DCM); IR (NaCl) n 3417, 2923, 2871, 136.6, 134.2, 131.2, 129.1, 128.1, 127.4, 127.3, 126.1, 123.4,
2110, 1720, 1454, 1364 cmꢁ1.; 1H NMR (400 MHz, CDCl3) d 7.37– 101.5, 98.2, 96.7, 78.8, 74.6, 74.2, 72.7, 72.4, 69.5, 68.5, 67.3,
7.27 (m, 8.4H), 5.33 (d, J ¼ 10.0 Hz, 0.7H), 5.30 (d, J ¼ 3.2 Hz, 66.3, 65.8, 55.5, 25.4, 21.1, 20.4, 17.8, ꢁ4.6, ꢁ5.4; HRMS
1H), 4.78 (dd, J ¼ 10.2, 8.7 Hz, 0.9H), 4.58–4.54 (m, 3H), 4.08 (ESI, M + Na+) calcd for C44H52N4O13SiNa 895.31978, found
(ddd, J ¼ 9.2, 5.7, 2.8 Hz, 1H), 3.74 (t, J ¼ 3.1 Hz, 0.8H), 3.72 (d, J 895.3181.
This journal is © The Royal Society of Chemistry 2019
RSC Adv., 2019, 9, 33853–33862 | 33859